Article Details

Zenas raises $200m to advance autoimmune antibody therapy

Retrieved on: 2024-05-08 15:35:22

Tags for this article:

Click the tags to see associated articles and topics

Zenas raises $200m to advance autoimmune antibody therapy. View article details on hiswai:

Excerpt

The investors included multiple US-based venture capital companies such as SR One, New Enterprise Associates (NEA), Norwest Venture Partners, Delos ...

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up